Researchers shed new light on G-quadruplexes, a type of secondary DNA structure that has attracted attention as a potential therapeutic target in cancer. Every day, billions of cells in your body ...
€15M, 3-year financing agreement with TECHLIFE CAPITAL and ELAIA PARTNERS First installment payment of €4M in July 2021 Objective to double its production capacity by 2022 Expand clinical batch ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback